Skip to main content

STEM CELLS INJECTED DIRECTLY INTO NON-AMBULATORY STROKE PATIENTS ALLOWS THEM TO WALK AGAIN

A new study involving stem cells at Stanford has given non-ambulatory stroke patients a new lease on life by injecting stem cells directly into a non-ambulatory stroke victim’s brain. As a result, the stroke survivors showed significant improvements.

The Stanford neurosurgeon who performed 12 of the 18 stem cell procedures as part of the study, Dr. Gary Steinberg, commented on his own amazement at the success of the study.

“This wasn’t just, ‘They couldn’t move their thumb, and now they can.’ Patients who were in wheelchairs are walking now.”

However, seeing such incredible progress as a result of the stem cells may be exaggerated – not so much in the success of the sample subjects, but in the sample size itself. Such a small control group of 89 subjects could mean that the results were the product of something like a fluke or a placebo effect. What’s more, the stem cell injections didn’t mean life changing effects on all of the stroke victims.

The study at Stanford wasn’t actually intended to make wheelchair-bound individuals independently mobile again by injecting their brains with stem cells. The primary purpose of the study was primarily conducted to determine whether the injection of stem cells directly into the brain would cause any untoward side effects. However, whereas the condition of some of the non-ambulatory stroke victims bore no benefits from the injection of stem cells, there was a clear benefit to many others. Some of the stroke victims gained a minimal movement in their fingers or toes, and some were actually able to stand and walk again.

As to the stem cell test subjects, each of them had suffered a stroke at least five years before the study. This meant that each of the stroke survivors had reached what doctors perceive as the limit of how much rehabilitation or physical therapy can help them. The purpose of the stem cell study – in addition to the search for adverse side effects – was to see if stem cell injections might have some effect in helping to rebuild damaged parts of the brain. When someone has a stroke, blood flow is blocked to the brain, cutting off its oxygen and leaving parts of it highly damaged. As a result, stroke victims may have issues with speech, and physical limitations utilizing their arms and legs.

The stem cells that were used in the study were donated. They were injected into the stroke victims’ brains and targeted near the area of the brain thought to be damaged by the stroke the survivors had endured. Doctors said that as a part of the procedure, side effects included nausea, depression, and headaches. However, no further severe side effects were discovered in the initial trial. Based on stem cell injection studies in rats, stem cells are only thought to survive for about a month once they are injected into an organism. As a result of this study, though, doctors say that some of the stroke survivors that were injected with the stem cells are still improving even as much as a year after the injection.

Currently, all treatments for stroke survivors need to be utilized in the first few hours after the stroke has occurred. Clearly, that is the reason why researchers are striving so hard to figure out new ways of healing damaged parts of the brain brought on by strokes. If the stem cell injection procedure can be better understood, it may lead to new treatments that can assist stroke survivors in making full recoveries regardless of when they experienced their stroke.

The Stanford study on stem cell injections in stroke survivors in published in the journal, Stroke.

Source by : http://goo.gl/Q3ix2c

Comments

Popular posts from this blog

The Dawn Of A New Era Of Regenerative Medicine: Tissue Engineering Comes Of Age

The Dawn Of A New Era Of Regenerative Medicine: Tissue Engineering Comes Of Age   The field of regenerative medicine reached a remarkable milestone recently when four women regained full sexual function after the successful implantation of lab-grown vaginas created from their own cells. The women, aged thirteen to eighteen, were born with a rare medical condition called Mayer-Rokitansky-Küster-Hauser syndrome (MRKHS) which left them with an abnormal or missing vagina. Each woman underwent a newly engineered procedure that involved taking samples of the patient's own cells and growing them into tissue. This tissue was then placed on a scaffold that was hand-sewn with collagen-like fibers and uniquely shaped to fit each woman’s vaginal cavity. Once the organ fully matured, it was implanted into a canal in each woman’s pelvis, along with the hand-sewn scaffolding. Within six months, the biodegradable scaffolding dissolved and, in each of the four women, the lab-grown vaginas began fun...

Black fungus detected in Covid-19 survivors, 8 lose eyesight in Surat | MUCORMYCOSIS

 Black fungus detected in Covid-19 survivors, 8 lose eyesight in Surat | MUCORMYCOSIS At least 40 cases of mucormycosis, also known as black fungus, have been reported from Surat in Gujarat among those who have recovered from Covid-19. Of the 40, eight have lost their eyesight. What is this infection and who is more vulnerable? Cases of mucormycosis, commonly known as black fungus, have been reported from Gujarat among those who have recovered from Covid-19. The number of such cases has increased as Gujarat sees an exponential rise in coronavirus infections. At least eight persons were reported to have lost their eyesight in Surat due to mucormycosis (MM) after recovering from Covid-19. They had to be admitted to hospitals for the sudden loss of vision. In the past 15 days, Surat has reported at least 40 cases of mucormycosis or black fungus including eight who have lost their eyesight. The infection, triggered by Covid-19, is treatable but if left untreated or if the treatment is ...

US Moves to Shut Down 2 Big Stem Cell Therapy Clinics

Federal authorities Wednesday moved to shut down two of the country’s most prominent for-profit providers of stem cell therapy, one of them a network of clinics with more than 100 offices in the United States, including several in the Bay Area. The Food and Drug Administration filed two complaints in federal court requesting permanent injunctions that would stop Florida-based U.S. Stem Cell Clinic and the California Stem Cell Treatment Center from marketing therapies. Both companies have previously been called out by the FDA for providing unproven, unapproved therapies that could put patients at risk. The injunction requests are an aggressive move by the FDA to patrol the consumer stem cell market. The agency has come under mounting pressure by scientists and patient advocates to increase oversight of the growing consumer market, which has been allowed to flourish for years. “In the two cases filed today, the clinics and their leadership have continued to disregard th...